Advanced search
Publication Cover
Cytotherapy Volume 14, 2012 - Issue 7
Journal homepage
231
Views
11
CrossRef citations to date
0
Altmetric
Research Article

A clinically adaptable method to enhance the cytotoxicity of natural killer cells against B-cell malignancies

Noriko ShimasakiDepartment of Oncology;Department of Paediatrics, National University of Singapore, Singapore
,
Hiroyuki FujisakiDepartment of Oncology
,
Duck ChoDepartment of Oncology
,
Marika MasselliDepartment of Oncology
,
Timothy LockeyDepartment of Therapeutic Production and Quality, St Jude Children's Research Hospital, Memphis, Tennessee, USA
,
Paul EldridgeDepartment of Therapeutic Production and Quality, St Jude Children's Research Hospital, Memphis, Tennessee, USA
,
Wing LeungDepartment of Oncology
&
Dario CampanaDepartment of Oncology;Department of Pathology;Department of Paediatrics, National University of Singapore, SingaporeCorrespondence[email protected] [email protected]
 show all
Pages 830-840 | Received 25 Oct 2011, Accepted 19 Feb 2012, Published online: 29 Mar 2012

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (11)

Mina Hosseini, Zahra Habibi, Narges Hosseini, Sina Abdoli & Nima Rezaei. (2022) Preclinical studies of chimeric antigen receptor-modified natural killer cells in cancer immunotherapy: a review. Expert Opinion on Biological Therapy 22:3, pages 349-366.
Read now
Kajal Chaudhry, Ehsan Dowlati & Catherine M. Bollard. (2021) Chimeric antigen receptor-engineered natural killer cells: a promising cancer immunotherapy. Expert Review of Clinical Immunology 17:6, pages 643-659.
Read now
A. Graham Pockley, Peter Vaupel & Gabriele Multhoff. (2020) NK cell-based therapeutics for lung cancer. Expert Opinion on Biological Therapy 20:1, pages 23-33.
Read now
Stefan Grote, Joerg Mittelstaet, Caroline Baden, Kenneth Chun-Ho Chan, Christian Seitz, Patrick Schlegel, Andrew Kaiser, Rupert Handgretinger & Sabine Schleicher. (2020) Adapter chimeric antigen receptor (AdCAR)-engineered NK-92 cells: an off-the-shelf cellular therapeutic for universal tumor targeting. OncoImmunology 9:1.
Read now
Lisa Marie Reindl, Nawid Albinger, Tobias Bexte, Stephan Müller, Jessica Hartmann & Evelyn Ullrich. (2020) Immunotherapy with NK cells: recent developments in gene modification open up new avenues. OncoImmunology 9:1.
Read now
Challice L. Bonifant, Mireya Paulina Velasquez & Stephen Gottschalk. (2018) Advances in immunotherapy for pediatric acute myeloid leukemia. Expert Opinion on Biological Therapy 18:1, pages 51-63.
Read now
Shannon Murray & Andreas Lundqvist. (2016) Targeting the tumor microenvironment to improve natural killer cell-based immunotherapies: On being in the right place at the right time, with resilience. Human Vaccines & Immunotherapeutics 12:3, pages 607-611.
Read now
Hans Klingemann. (2014) Are natural killer cells superior CAR drivers?. OncoImmunology 3:4.
Read now
Yu-Hsiang Chang & Dario Campana. (2013) Increasing the antineoplastic potential of natural killer cells with a chimeric receptor activated by NKG2D ligands. OncoImmunology 2:7.
Read now
Natalia Lapteva, April G. Durett, Jiali Sun, Lisa A. Rollins, Leslie L. Huye, Jian Fang, Varada Dandekar, Zhuyong Mei, Kimberley Jackson, Juan Vera, Jun Ando, Minhtran C. Ngo, Elaine Coustan-Smith, Dario Campana, Susann Szmania, Tarun Garg, Amberly Moreno-Bost, Frits Vanrhee, Adrian P. Gee & Cliona M. Rooney. (2012) Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications. Cytotherapy 14:9, pages 1131-1143.
Read now
John C. Riches & John G. Gribben. (2012) Less expensive CARs?. Cytotherapy 14:7, pages 773-774.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.